Company Long-Term Loans and Borrowings: Revelation Bio (REVB)
This chart reflects the price trend for Revelation Biosciences (REVB), showing asset dynamics with a value of 0.00. Management is focusing on developing agents to correct immune responses in allergies and infections to attract strategic investors. The operating model relies on outsourcing biopharmaceutical production in North America and utilizing diversified logistics channels for the rapid delivery of essential reagents.
Revelation Bio (REVB) - metric breakdowns and financial figures
- market price and analyst price targets:
- company stock exchange capitalization indicators:
- book capitalization information:
- debt level and financial liquidity data:
All Debt to Shareholders' Equity Ratio Revelation Biosciences|REVB - Long-Term Debt to Capital|Short-Term Debt to Capital Coefficient Revelation Biosciences Corp|REVB - Company Debts|Debt to Book Value Revelation Biosciences|REVB - Company Long-Term Debt|Company Current Liabilities Revelation Biosciences|Quick Ratio revbiosciences.com
- earnings and multiples data:
Analysis of all company metrics:REVB - revbiosciences.com
This indicator captures the total volume of obligations with a maturity of more than one year, determining the issuer's long-term solvency. By analyzing the dynamics of the corporation's long-term loans and borrowings, an investor assesses the balance between leveraged capital and financial stability. For Revelation Biosciences (REVB), these resources are critical when organizing the complex logistics of biopharmaceutical raw materials. The stability of liabilities guarantees the uninterrupted supply of reagents for immunological research. Monitoring this metric confirms the reliability of the asset.
Competitors of Revelation Biosciences (REVB)
Company Long-Term Debts argenx.com ARGX|BNTX - Company Long-Term Debt|Company Long-Term Loans and Borrowings ABVX (abivax.com)|ADMA Bio (ADMA) - Company Long-Term Debt|Company Long-Term Liabilities Protagonist Corp|IMVT (Immunovant, Inc.) - Company Long-Term Debts|Company Long-Term Debts kiniksa.com|Company Long-Term Liabilities GRFS (Grifols)|ADPT (Adaptive Biotech) - Company Long-Term Loans and Borrowings|Company Long-Term Debts CLDX (Celldex)|Long-Term Debt Volume Aurinia Corp (AUPH)|BCRX - Company Long-Term Debt|veratx.com (VERA) - Company Long-Term Liabilities|Dianthus Therapeutics, Inc. (DNTH) - Company Long-Term Debt|Company Long-Term Liabilities Pharvaris NV|Company Long-Term Liabilities ABCL|Company Long-Term Debts Tourmaline|Company Long-Term Debt Precigen, Inc. (PGEN)|pharming.com - Company Long-Term Indebtedness|Company Long-Term Debts NKTR (Nektar Therapeutics Inc.)|Upstream Bio, Inc. (UPB) - Long-Term Debt|ZBIO - Company Long-Term Debt|Company Long-Term Loans and Borrowings IMNM (Immunome Bio)|GOSS: Company Long-Term Debts|Long-Term Debt kalvista.com (KALV)|Company Long-Term Liabilities SEPN|Company Long-Term Debt PVLA|Company Long-Term Debts SVRA|RIGL - Long-Term Debt|Company Long-Term Debt AnaptysBio, Inc. ANAB|astriatx.com - Company Long-Term Debt|enGene - Company Long-Term Debts|RAPT - Company Long-Term Debts|JBIO (aerovatetx.com) - Company Long-Term Liabilities|ACRS: Amount of Long-Term Liabilities|KYTX (Kyverna Therapeutics) - Company Long-Term Debts|tizianalifesciences.com (TLSA) - Long-Term Debt Volume|Company Long-Term Debt Cabaletta Bio (CABA)|VTYX - Long-Term Debt|Company Long-Term Debt Theratechnologies Inc THTX|AVTX: Company Long-Term Indebtedness|ELDN: Company Long-Term Liabilities|Company Long-Term Loans and Borrowings AGEN (agenusbio.com)|CLYM: Company Long-Term Debts|ZURA (zurabio.com) - Company Long-Term Debt|ATYR (aTyr) - Company Long-Term Debts|Adagene Corp (ADAG) - Long-Term Debt Volume|Company Long-Term Debt ImageneBio Inc (IMA)|STTK - Long-Term Debt|Company Long-Term Debt Equillium EQ|Long-Term Debt Volume Connect Biopharma Holdings (CNTB)|Immunic Inc - Company Long-Term Debts|Atara Biotherapeutics (ATRA) - Company Long-Term Liabilities|IFRX: Company Long-Term Debts|XFOR - Long-Term Debt Volume|ACET (Adicet Bio Inc.) - Company Long-Term Debts|Long-Term Debt Celularity Corp CELU|Company Long-Term Debt INmune Bio Corp (INMB)|Barinthus Biotherapeutics Corp - Company Long-Term Indebtedness|Company Long-Term Debts KZR (Kezar Life Sciences)|SABS - Company Long-Term Liabilities|Akari Therapeutics Plc - Company Long-Term Debts|Long-Term Debt Enlivex Therapeutics|q32bio.com (QTTB) - Company Long-Term Debt|GOVX - Long-Term Debt Volume|Company Long-Term Debt Edesa Biotech, Inc.|IBIO: Company Long-Term Loans and Borrowings|Company Long-Term Debts CARM|XTLB - Long-Term Debt|Bolt Biotherapeutics, Inc. - Company Long-Term Liabilities|HCW Biologics, Inc. - Company Long-Term Debt|Aptevo - Company Long-Term Debts|AIM: Company Long-Term Debt|aditxt.com (ADTX) - Company Long-Term Debt|Long-Term Liabilities GRI (GRI Bio Inc)|XRTX (XORTX) - Company Long-Term Debts|HIND: Company Long-Term Loans and Borrowings|Company Long-Term Debts INDP|Company Long-Term Debts scinai.com (SCNI)|Company Long-Term Debt CalciMedica CALI|Company Long-Term Loans and Borrowings AFMD|ALLK - Company Long-Term Debt|HOOKIPA Pharma Inc. (HOOK) - Company Long-Term Liabilities|IGMS: Company Long-Term Debts|iteostherapeutics.com (ITOS) - Company Long-Term Debts|Company Long-Term Liabilities OCEA|TCBP: Company Long-Term Loans and Borrowings|Company Long-Term Debts THRD